Document is current
Any future updates will be listed below
-
Authors
Frost, Fabian
Weiss, Stefan
Hertel, Johannes
Rühlemann, Malte
Bang, Corinna
Franke, Andre
Nauck, Matthias
Dörr, Marcus
Völzke, Henry
Roggenbuck, Dirk
Schierack, Peter
Völker, Uwe
Homuth, Georg
Aghdassi, Ali A.
Sendler, Matthias
Lerch, Markus M.
Weiss, Frank U.
-
Funding
Funding for this research was provided by:
Universitätsmedizin Greifswald
- License Information
-
More Information
Article History
Received: 3 July 2024
Accepted: 10 October 2024
First Online: 19 October 2024
Declarations
:
: All participants provided written informed consent and the study was approved by the local ethics committee of the University Medicine Greifswald (BB 39/08 and BB 122/13).
: Not applicable.
: Dirk Roggenbuck is a shareholder of GA Generic Assays GmbH and Medipan GmbH. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
